Ionis Pharmaceuticals | IONS - Fremdkapital





Fremdkapital Veränderung Datum
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Arrowhead Research USD 1.23B 687.3M 2026-03
Astellas Pharma JPY 320B 0 2026-03
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Celltrion KRW 411.27B 998.23M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Divis Laboratories Ltd INR 50M 30M 2026-03
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 603M 7M 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.45B 7.86B 2026-03
Omeros USD 403.72M 27.2M 2024-06
OPKO Health USD 336.03M 1.08M 2026-03
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 60.57B 1.08B 2026-03
Pharma Mar EUR 33.16M 3.52M 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Qiagen NV USD 1.65B 7.87M 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 25.22B 2.21B 2026-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tilray USD 268.59M 3.82M 2025-09
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03